This inventor holds 3 USPTO granted patents. Top assignee: The Florida State University Research Foundation, Inc.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Eduard Y Chekmenev: Innovator in Solid State NMR Spectroscopy
Introduction
Eduard Y Chekmenev is a prominent inventor based in Pasadena, California. He has made significant contributions to the field of solid-state nuclear magnetic resonance (NMR) spectroscopy, particularly in the context of drug candidate screening for cell membrane proteins. With a total of 3 patents, his work is paving the way for advancements in pharmaceutical research.
Latest Patents
One of Chekmenev's latest patents involves a solid-state NMR method for screening cell membrane protein binding drug candidates. This innovative method begins by forming a lipid bilayer within nanopores of an anodic aluminum oxide (AAO) substrate, which contains a membrane protein sample. The AAO substrate is then treated with various candidate ligands that may have binding affinity for the membrane protein. Solid-state NMR analysis is conducted on the treated AAO/lipid preparation to generate an NMR spectrum for the treated membrane protein. By comparing the solid-state NMR spectrum of the treated membrane protein with that of the same preparation in the absence of ligands, it can be determined if there has been a shift in the spectrum. This shift indicates potential protein binding by the candidate ligand.
Career Highlights
Eduard Y Chekmenev is affiliated with the Florida State University Research Foundation, Inc., where he continues to advance his research in NMR spectroscopy. His work has garnered attention for its potential applications in drug discovery and development.
Collaborations
Chekmenev has collaborated with notable colleagues, including Timothy A Cross and William W Brey, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Eduard Y Chekmenev's innovative contributions to solid-state NMR spectroscopy are significant in the realm of drug candidate screening. His work not only showcases his expertise but also holds promise for future advancements in pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
